TFEB dysregulation has been reported in several neurodegenerative diseases, mainly by reduced nuclear localization, such as in the postmortem brains of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis patients [33,34,35]. This evidence concerns the gene TFEB and Parkinson disease.